Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Reversibility of the Bronchial Obstruction by Impulse Oscillometry Technique in Chronic Obstructive Pulmonary Disease (COPD): Correlation With Functional Features Measured by Plethysmography and Dyspnoea

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* COPD with dyspnoea with Medical Research Council scale (MRC) \>1,~* No exacerbation for 6 weeks~* No bronchodilatator short action(share) (ß 2 agonist or ipratropium) within 6 hours before the respiratory evaluation and the test of reversibility.~* Patient under current treatment (ß2 long-acting agonist (LABA) or anticholinergic long-acting (LLAMA(LAMA)) or LABA-corticoid association inhaled (CSI), or triples LABA-CSI-LAMA association) stable for at least 4 weeks, and taken for at least the 1 hour the day of the visit~* Having given a written consent~Exclusion Criteria:~* Patient Under 18~* Other respiratory illness~* Clinically significant left cardiac failure~* Obesity with BMI \> 35 kg / m2)~* Unable to perform respiratory evaluations~* Contraindication to the salbutamol or to the ipratropium bromide or to one of its components~* Pregnant or breast-feeding woman~* Unable to agree~* No social security scheme

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- COPD (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).